Paper of the Month - May, 2011

0 rating

Iniparib plus chemotherapy in metastatic triple-negative breast cancer.

O’Shaughnessy J, Osborne C, Pippen JE et al.



READER POLL

Breast Cancer Poll 1
What approach do you currently use for the treatment of patients with HER2-overexpressing metastatic breast cancer whose disease has progressed despite trastuzumab?






Powered by NetPolls

WEB LINKS

SUBMIT AN ARTICLE